A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

BACKGROUND: This multicenter, phase II trial tested the tolerability and efficacy of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma (FL). PATIENTS AND METHODS: Patients with grade 1–3a FL, stage 3–4 or bulky stage 2, FL international prognostic index (FLIPI) 0–...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Ann Oncol
मुख्य लेखकों: Martin, P, Jung, S -H, Pitcher, B, Bartlett, N L, Blum, K A, Shea, T, Hsi, E D, Ruan, J, Smith, S E, Leonard, J P, Cheson, B D
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2017
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5789808/
https://ncbi.nlm.nih.gov/pubmed/28945884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx496
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन